Core Viewpoint - Quantum BioPharma Ltd. is set to host a Business Update Conference Call on May 6, 2025, to discuss its year-end financial results, regulatory initiatives, commercial-readiness activities, and anticipated milestones [1][2]. Group 1: Conference Call Details - The conference call will be led by CEO Zeeshan Saeed and Head of Finance and M&A Jason Sawyer, followed by a Q&A session [2]. - The call is scheduled for May 6, 2025, at 4:30 p.m. Eastern time, with dial-in and webcast access provided [2]. - A telephone replay will be available approximately three hours after the call and will run until August 6, 2025 [2]. Group 2: Company Overview - Quantum BioPharma is focused on developing innovative biopharmaceutical solutions for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders [3]. - The company’s lead compound, Lucid-MS, is designed to prevent and reverse myelin degradation associated with multiple sclerosis, showing promise in preclinical models [3]. - Quantum BioPharma retains a 25.71% ownership stake in Celly Nutrition, which markets the unbuzzd™ product, and is entitled to a 7% royalty on sales until reaching $250 million, after which the royalty will decrease to 3% [3].
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time